Vogel, Slade & Goldstein LLP https://validator.w3.org/feed/docs/rss2.html Contact VSG CVS to Pay $37.76M to Settle Whistleblower Allegations That It Overbilled Government Healthcare Programs for Excessive Amounts of Insulin Vogel, Slade & Goldstein Strengthens Award-Winning Qui Tam Team with Addition of Former Federal Prosecutor Gwendolyn A. Stamper Gwendolyn A. Stamper Janet L. Goldstein Shelley R. Slade How VSG Whistleblower Attorneys Work About VSG Robert L. Vogel Legal Staff Best Lawyers® Names VSG Partner Janet Goldstein the 2025 “Lawyer of the Year” in Qui Tam Law in Washington, D.C. Civil Cyber Fraud Practice Areas Best Lawyers® Names VSG Partner Shelley Slade a Best Qui Tam Lawyer and Qui Tam Lawyer of the Year in DC for 2024 Walgreens, Stephen L. LaFrance Holdings Co. and Other USA Drug Chain Pharmacies Pay $16 Million to Resolve False Claims Act Overbilling Case Cybersecurity Fraud Department of Defense Contractor Cybersecurity Requirements Tips for Potential Cybersecurity Whistleblowers NASA Contractor Cybersecurity Requirements GSA Public Buildings Service Contractor Cybersecurity Requirements Best Lawyers® names VSG Partner Janet Goldstein a Best Qui Tam Lawyer for 2024 Generally Applicable Cybersecurity Requirements Do You Need Whistleblower Protection against Retaliation? Department of Justice Officials Explain New Civil Cyber-Fraud Initiative Best Lawyers<sup>®</sup> Names VSG Partner Shelley Slade a Best Qui Tam Lawyer and Qui Tam Lawyer of the Year in DC Best Lawyers<sup>®</sup> names VSG Partner Janet Goldstein a Best Qui Tam Lawyer DOJ Moves to Dismiss Just Under 4% of Whistleblower Filings VSG Recommends Tom Mueller’s New Book on Whistleblowing Pharmaceutical Fraud Violations of Good Manufacturing Practices Off-Label Marketing Kickbacks Violations of Usual & Customary Charges Violations of Prescriptions and Licensing Requirements CEO Pays $20M to Resolve SBA/VA Fraud Claims Alaskan Native Sub KICD Pays $2.025 Million to Resolve FCA-Kickback Case Former HMA CEO Gary Newsome Pays $3.5 Million to Settle Qui Tam Claims by VSG Clients Medicare Part D Sponsor Fraud and the False Claims Act Off-Label Marketing Drug Manufacturer Kickbacks to Specialty Pharmacies Violating Usual & Customary Charge Requirments National Chain Pharmacy Over-Bills Medicare and Medicaid for Insulin Pens Kickbacks to Long Term Care Pharmacy Drug Manufacturer Kickback on Specialty Medications Evading Caps on Reimbursement for Services Drug Switching to Inflate Medicaid Reimbursement Drug Manufacturer Kickbacks on Generic Drugs Whistleblower Settlements Walgreens Pharmacy Chain Pays $209 Million to Settle VSG Clients’ Lawsuit Alleging Over-Dispensing of Insulin Home